Toll-like Receptor 4, Toll-like Receptor 7 and Toll-like Receptor 9 Agonists Enhance Immune Responses Against Blood-Stage Plasmodium Chabaudi Infection in BALB/c Mice.

Wenyan Gao,Xiaodan Sun,Danni Li,Lin Sun,Yang He,Huanping Wei,Feng Jin,Yaming Cao
DOI: https://doi.org/10.1016/j.intimp.2020.107096
IF: 5.714
2020-01-01
International Immunopharmacology
Abstract:Background: Toll-like receptor (TLR) signals play vital roles during the blood-stage of malaria infections. However, the roles of TLR agonists in the regulation of immune responses and the development of protective immunity to malaria remain poorly understood. Method: BALB/c mice were pre-treated with TLR4, TLR7 and TLR9 agonists, followed by infection with Plasmodium chabaudi. After infection, splenic dendritic cells (DCs), Th1 cells and programmed death-1 (PD-1) expressed on Th1 cells, as well as regulatory T cells (Tregs) were analyzed by flow cytometry. The levels of IFN-gamma, TNF-alpha, TGF-beta and IL-10 in splenocytes and IgG1 and IgG2a in serum were measured by ELISA. Result: Administration of TLR4, TLR7 and TLR9 agonists prior to infection improved disease outcomes. All TLR agonists promoted DC activation, and the proportions of Th1 cells increased. In TLR4, TLR7 and TLR9 agonist treated groups the levels of pro-inflammatory cytokines IFN-gamma and TNF-alpha were elevated, and IgG1 and IgG2a serum levels were also significantly increased. TLR4, TLR7 and TLR9 agonists diminished the activation of Tregs and down-regulated the anti-inflammatory cytokines TGF-beta and IL-10. Finally, PD-1 expressed on Th1 cells were decreased in TLR4, TLR7 and TLR9 agonist treated groups compared with control groups. Conclusion: TLR4, TLR7 and TLR9 agonists activated DC-mediated innate immune responses and adaptive immune response, which against the blood-stage of Plasmodium and might be applied to malaria protection and treatment.
What problem does this paper attempt to address?